Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Sep 25, 2023

SELL
$238.39 - $265.32 $4.72 Million - $5.25 Million
-19,806 Reduced 62.18%
12,049 $3.18 Million
Q2 2023

Aug 14, 2023

SELL
$238.39 - $265.32 $4.72 Million - $5.25 Million
-19,806 Reduced 62.18%
12,049 $3.18 Million
Q1 2023

Sep 25, 2023

BUY
$229.71 - $259.35 $4.55 Million - $5.14 Million
19,806 Added 164.38%
31,855 $7.89 Million
Q1 2023

May 15, 2023

BUY
$229.71 - $259.35 $7.32 Million - $8.26 Million
31,855 New
31,855 $7.89 Million
Q2 2022

Nov 16, 2022

BUY
$234.74 - $275.42 $2.69 Million - $3.16 Million
11,464 New
11,464 $2.83 Million
Q2 2022

Aug 15, 2022

SELL
$234.74 - $275.42 $1.4 Million - $1.65 Million
-5,978 Reduced 34.27%
11,464 $2.83 Million
Q4 2021

Feb 14, 2022

BUY
$230.08 - $250.94 $388,835 - $424,088
1,690 Added 10.73%
17,442 $4.28 Million
Q3 2021

Nov 16, 2021

BUY
$232.72 - $256.47 $3.67 Million - $4.04 Million
15,752 New
15,752 $3.78 Million

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $65.1B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Brookfield Asset Management Inc. Portfolio

Follow Brookfield Asset Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brookfield Asset Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Brookfield Asset Management Inc. with notifications on news.